The oxidosqualene cyclase family of Rosa rugosa (RrOSC) provides a starting point for the triterpenoid pathway, which contributes to the medicinal value of the extraction of tissues of Rosa rugosa. However, the structure and function of key RrOSCs of active triterpenoids remain ambiguous. In this study, a total of 18 RrOSC members with conservative gene structures and motifs were identified based on the genome of Rosa rugosa. The RrOSCs were located on three chromosomes including two gene clusters that derived from gene replication. The phylogenetic relationship divided RrOSCs into six groups, and the RrOSCs of GI and GIV that were represented by lupeol or α-amyrin were identified as likely to include candidate genes for producing active triterpenoids. Considering the high expression or specific-tissue expression of the candidates, RrOSC1, RrOSC10, RrOSC12, and RrOSC18 were considered the key genes. RrOSC12 was identified in vitro as lupeol synthase. The results provided fundamental information and candidate genes for further illustration of the triterpenoid pathway involved in the pharmacological activities of Rosa rugosa.

Rosa rugosa is highly regarded for its aesthetic and therapeutic qualities. In particular, R. rugosa’s flowers are known to produce essential oils containing a mixture of volatile terpenes, phenylpropanoids, and other compounds. Despite this, extensive research exists on volatile terpenes in flowers, while the knowledge of non-volatile terpenes in distinct tissues is still limited. Using UPLC–ESI–MS/MS, a comprehensive analysis of the terpene metabolites in five different tissues of R. rugosa was conducted. These metabolites accumulated in distinct tissues, and the majority of them were triterpenoids. Transcriptome data were collected from five tissues using RNA-seq. Transcriptomics and metabolomics were utilized to evaluate the triterpene biosynthesis pathway, resulting in new insights into its regulation and biosynthesis. The RrOSC10 was identified as a key enzyme in converting 2,3-oxidosqualene into α-amyrin, potentially contributing to the triterpene biosynthesis pathway. Furthermore, the expression of the RrOSC10 gene was upregulated by salinity for 0.5 h and 1 h, with subsequent downregulation at 2 h. This study lays a foundation for future research on the biosynthesis and accumulation of triterpenes in R. rugosa.

Rosa rugosa is an important ornamental and edible species that is valued for its floral colors and essential oils in the cosmetic and pharmaceutical industries. Carotenoids, beyond their health-promoting roles, function as accessory pigments that influence petal coloration, flower quality, and stress responses. However, their accumulation patterns and molecular biosynthesis in R. rugosa remain poorly understood. Here, UPLC-APCI-MS/MS analysis across three developmental stages (bud, semi-open, and full bloom) revealed stage-specific carotenoid accumulation, with phytoene and phytofluene markedly increasing at the semi-open stage. In total, 11 carotenoids were identified, comprising four carotenes and seven xanthophylls. Differential accumulation of metabolites (DAMs) analysis indicated shifts in compounds, including (E/Z)-phytoene, phytofluene, and β-carotene across stages. Genetic complementation assays in Escherichia coli and transient overexpression in rose petals confirmed that RrPSY1 functions as a phytoene synthase. qRT-PCR results showed its upregulation under salt treatment, suggesting a role in enhancing stress tolerance through carotenoid-mediated antioxidant protection. Furthermore, sub-cellular localization experiments confirmed plastid targeting of RrPSY1. Together, these findings clarify the role of RrPSY1 in carotenoid biosynthesis and provide a foundation for future studies on metabolic regulation and biosynthesis of carotenoids in R. rugosa.